Clinical Trial

Establishment of Human Lung Stem Cell Proliferation System and Organoid Construction in COPD

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 10, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this study is to proliferate human lung stem cell in vitro in order to establish a lung organoid derived from patients with COPD. The main question it aims to answer are: * Can human lung stem cell proliferate in vitro. * Can a lung organoid derived from patients with COPD be established. Participants will be sampled during pulmonary bronchoscope for organoid establishment.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-02-22.
Status change: Not Yet Recruiting → Recruiting 2025-02-07
Trial Details
NCT Number NCT06275230
Lead Sponsor China-Japan Friendship Hospital
Conditions Chronic Obstructive Pulmonary Disease
Enrollment 30 participants
Start Date 2024-03-20
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-10